163 related articles for article (PubMed ID: 20633696)
1. Metabolic signatures of malignant progression in prostate epithelial cells.
Teahan O; Bevan CL; Waxman J; Keun HC
Int J Biochem Cell Biol; 2011 Jul; 43(7):1002-9. PubMed ID: 20633696
[TBL] [Abstract][Full Text] [Related]
2. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE
Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the chemopreventive potential of retinoids using a novel in vitro human prostate carcinogenesis model.
Quader ST; Bello-DeOcampo D; Williams DE; Kleinman HK; Webber MM
Mutat Res; 2001 Sep; 496(1-2):153-61. PubMed ID: 11551491
[TBL] [Abstract][Full Text] [Related]
4. Selection of cell lines with enhanced invasive phenotype from xenografts of the human prostate cancer cell line WPE1-NB26.
Rivette AS; Tokar EJ; Williams DE; Mackenzie CD; Ablin RJ; Webber MM
J Exp Ther Oncol; 2005; 5(2):111-23. PubMed ID: 16471037
[TBL] [Abstract][Full Text] [Related]
5. NMR-based metabolomics approach to target biomarkers for human prostate cancer.
Jordan KW; Cheng LL
Expert Rev Proteomics; 2007 Jun; 4(3):389-400. PubMed ID: 17552923
[TBL] [Abstract][Full Text] [Related]
6. Detection of metabolic alterations in non-tumor gastrointestinal tissue of the Apc(Min/+) mouse by (1)H MAS NMR spectroscopy.
Backshall A; Alferez D; Teichert F; Wilson ID; Wilkinson RW; Goodlad RA; Keun HC
J Proteome Res; 2009 Mar; 8(3):1423-30. PubMed ID: 19159281
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative effects of physiological concentrations of enterolactone in models of prostate tumourigenesis.
McCann MJ; Rowland IR; Roy NC
Mol Nutr Food Res; 2013 Feb; 57(2):212-24. PubMed ID: 23148045
[TBL] [Abstract][Full Text] [Related]
8. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer.
Nanni S; Priolo C; Grasselli A; D'Eletto M; Merola R; Moretti F; Gallucci M; De Carli P; Sentinelli S; Cianciulli AM; Mottolese M; Carlini P; Arcelli D; Helmer-Citterich M; Gaetano C; Loda M; Pontecorvi A; Bacchetti S; Sacchi A; Farsetti A
Mol Cancer Res; 2006 Feb; 4(2):79-92. PubMed ID: 16513839
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
11. Basal cell induced differentiation of noncancerous prostate epithelial cells (RWPE-1) by glycitein.
Clubbs EA; Bomser JA
Nutr Cancer; 2009; 61(3):390-6. PubMed ID: 19373613
[TBL] [Abstract][Full Text] [Related]
12. Prostate carcinogenesis induced by N-methyl-N-nitrosourea (mnu) in gerbils: histopathological diagnosis and potential invasiveness mediated by extracellular matrix components.
Gonçalves BF; Zanetoni C; Scarano WR; Góes RM; Vilamaior PS; Taboga SR; Campos SG
Exp Mol Pathol; 2010 Feb; 88(1):96-106. PubMed ID: 19818764
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers associated with prostate cancer progression.
Zhau HE; Pisters LL; Hall MC; Zhao LS; Troncoso P; Pollack A; Chung LW
J Cell Biochem Suppl; 1994; 19():208-16. PubMed ID: 7529853
[TBL] [Abstract][Full Text] [Related]
14. The role of alpha 6 beta 1 integrin and EGF in normal and malignant acinar morphogenesis of human prostatic epithelial cells.
Bello-DeOcampo D; Kleinman HK; Webber MM
Mutat Res; 2001 Sep; 480-481():209-17. PubMed ID: 11506815
[TBL] [Abstract][Full Text] [Related]
15. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification.
Nam H; Chung BC; Kim Y; Lee K; Lee D
Bioinformatics; 2009 Dec; 25(23):3151-7. PubMed ID: 19783829
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in metabolomics in oncology.
O'Connell TM
Bioanalysis; 2012 Feb; 4(4):431-51. PubMed ID: 22394143
[TBL] [Abstract][Full Text] [Related]
17. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.
Jiménez B; Montoliu C; MacIntyre DA; Serra MA; Wassel A; Jover M; Romero-Gomez M; Rodrigo JM; Pineda-Lucena A; Felipo V
J Proteome Res; 2010 Oct; 9(10):5180-7. PubMed ID: 20690770
[TBL] [Abstract][Full Text] [Related]
18. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
19. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines.
Webber MM; Bello D; Quader S
Prostate; 1996 Dec; 29(6):386-94. PubMed ID: 8977636
[TBL] [Abstract][Full Text] [Related]
20. Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer.
Jeet V; Ow K; Doherty E; Curley B; Russell PJ; Khatri A
Prostate; 2008 Apr; 68(5):548-62. PubMed ID: 18247402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]